Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | NFKB2 | Q00653 | 3/20 | 1.00 |
| ▸ | RELA | Q04206 | 3/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biochanin SCHEMBL61258 | 1.00 | RAB9A (1.00) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| 4',7-Dimethoxy-5-Hydroxygenistein SCHEMBL572108 | 0.93 | RAB9A (1.00) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| Formononetin SCHEMBL6312014 | 0.91 | MAPT (0.83) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| Formononetin SCHEMBL4223418 | 0.91 | MAPT (0.83) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| Genistein SCHEMBL18241115 | 0.89 | MEN1 (0.89) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL12238015 | 0.88 | SMN1; SMN2 (0.79) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL12892701 | 0.88 | RAB9A (0.81) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL26145339 | 0.88 | KDM4E (0.85) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13481416 | 0.88 | MEN1 (0.79) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 | |
| Prunetin SCHEMBL29612430 | 0.88 | ALDH2 (1.00) | RAB9AMAPTMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108488-A1 | PROCESS FOR PREPARING BIOCHANIN A-LOADED HYDROGEL FOR PROMOTING WOUND HEALING IN DIABETIC PATIENTS | ALGHAMDI ABEER S (SA) | 2026-04-23 | — | — | US | claimed |
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | claimed |
| EP-4125866-B1 | BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1-RELATED RETINOPATHIES | UNIV REGENSBURG (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-4101437-B1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2025-06-11 | — | — | EP | claimed |
| CN-119110720-A | Cosmetic composition | 布茨公司 | 2024-12-10 | — | — | CN | claimed |
| EP-3520785-B1 | USES OF BACTERIOSTATIC AGENT FORMULA IN PREPARING COMPOSITION FOR VAGINAL USE AND COMPOSITION FOR VAGINAL USE | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2024-07-17 | — | — | EP | claimed |
| CN-116990401-A | Method for analyzing three-white soup ingredients by using ultrahigh resolution liquid chromatography-mass spectrometry technology | 安徽中医药大学 | 2023-11-03 | — | — | CN | claimed |
| EP-3449943-B1 | A PHARMACEUTICAL COMPOSITION FOR IMPROVING OR PREVENTING PROGRESSION OF CHRONIC KIDNEY DISEASE | FRIMLINE PRIVATE LTD (IN) | 2022-08-31 | — | — | EP | claimed |
| US-12629351-B2 | HDAC inhibitors for idiopathic pulmonary fibrosis and other lung inflammatory disorders | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)) (IN) | 2026-05-19 | — | — | US | disclosed |
| US-20260108488-A1 | PROCESS FOR PREPARING BIOCHANIN A-LOADED HYDROGEL FOR PROMOTING WOUND HEALING IN DIABETIC PATIENTS | ALGHAMDI ABEER S (SA) | 2026-04-23 | — | — | US | disclosed |
| EP-3906040-B1 | COMBINATION OF CIMICIFUGA AND PETASITES EXTRACTS FOR ANTICANCER THERAPY AND PROPHYLAXIS | ZELLER MAX SOEHNE AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4208443-B1 | HDAC INHIBITORS FOR IDIOPATHIC PULMONARY FIBROSIS AND OTHER LUNG INFLAMMATORY DISORDERS | COUNCIL OF SCIENT AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER REGN OF SOC A (IN) | 2025-11-26 | — | — | EP | disclosed |
| US-12478605-B2 | Biochanin a derivatives for treatment of BEST1-related retinopathies | UNIVERSITÄT REGENSBURG (DE) | 2025-11-25 | — | — | US | disclosed |
| EP-2825624-B2 | WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-2838811-B2 | POWDERED POUCH AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2022-06-29 | — | — | EP | disclosed |
| CN-109415321-B | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2022-06-17 | — | — | CN | disclosed |
| WO-2022123428-A2 | POLYMERIC MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022049599-A1 | HDAC INHIBITORS FOR IDIOPATHIC PULMONARY FIBROSIS AND OTHER LUNG INFLAMMATORY DISORDERS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)) (IN) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022046522-A1 | SUPPLEMENT THAT ENHANCES INTRACELLULAR CONCENTRATION OF BIOACTIVE MOLECULES THROUGH INHIBITION OF MULTIDRUG RESISTANT (MDR) EFFLUX PUMPS | Brilliant Lab LLC (US) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629351-B2 | HDAC inhibitors for idiopathic pulmonary fibrosis and other lung inflammatory disorders | HDAC8, HDAC7, HDAC1 | RAB9A 1164/4885MAPT 4646/4885MEN1 4874/4885 |
| US-20260108488-A1 | PROCESS FOR PREPARING BIOCHANIN A-LOADED HYDROGEL FOR PROMOTING WOUND HEALING IN DIABETIC PATIENTS | VEGFA, HMOX2, HMOX1 | RAB9A 2806/4885MAPT 4057/4885MEN1 4872/4885 |
| US-12478605-B2 | Biochanin a derivatives for treatment of BEST1-related retinopathies | SORBS1, SLC5A6, SLC20A1 | RAB9A 1919/4885MAPT 1330/4885MEN1 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.